Urinary Catheters Market Size, Share, Growth Analysis, By Product(Indwelling Catheters, Intermittent Catheters, External Catheters), By Type(Coated Catheters, Uncoated Catheters), By Usage(Male Urinary Catheters, Female Urinary Catheters), By Application(Urinary Incontinence, General Surgery, Benign Prostatic Hyperplasia, Other Applications), By End User(Hospitals, Long-Term Care Facilities, Other End Users), By Region - Industry Forecast 2024-2031

Urinary Catheters Market size was valued at USD 2.2 billion in 2022 and is poised to grow from USD 2.32 billion in 2023 to USD 3.59 billion by 2031, growing at a CAGR of 5.6% during the forecast period (2024-2031).

The global urinary catheters market is quite competitive and relatively fragmented. Some of the major names in the sector include CR Bard, Cook Group, Medline Industries, ConvaTec Group Plc, and B Braun. These large companies offer a vast array of products for different purposes. Because silicone provides such a wide range of functions, there has been a significant shift on the major players from latex to silicone. These companies cover virtually every application within the urology market through their very large product line. 'Coloplast A/S  (Denmark) ', 'Becton, Dickinson and Company (BD) (US) ', 'Convatec Group Plc (UK) ', 'Cardinal Health (US) ', 'B. Braun Melsungen AG (Germany) ', 'Boston Scientific Corporation (US) ', 'Asid Bonz GmbH (Germany) ', 'Bactiguard (Sweden) ', 'Cook Medical (US) ', 'Cure Medical (US) ', 'Go Medical Industries Pty Ltd. (Australia) ', 'Hollister Incorporated (US) ', 'Teleflex Incorporated (US) ', 'Wellspect Healthcare (Sweden) (A subsidiary of Dentsply Sirona Inc.) ', 'Amsino International, Inc. (US) ', 'CompactCath (US) ', 'Degania Silicone Ltd. (Israel) (A part of Q Life Sciences) ', 'Hunter Urology (US) ', 'J And M Urinary Catheters LLC (US) ', 'Manfred Sauer GmbH (Germany) ', 'Medical Technologies of Georgia (US) ', 'Ribbel International Limited (UK) ', 'Rocamed (France) ', 'Urocare Products, Inc. (US) ', 'Well Lead Medical Co., Ltd. (China)'

The urinary catheters market is increasingly growing as the cases of urinary conditions, among which are benign prostatic hyperplasia, urinary tract infections, and urine incontinence, continue to rise. Demand for both intermittent and indwelling catheters is also on the rise since people are increasingly looking for treatment of the diseases. Due to the above growth trend, healthcare providers are bound to invest more in catheterization solutions, which presents a boom in their investment among older populations who are more susceptible to such urinary conditions. 

Shift towards Patient-Centric Products: Patient-centric urinary catheters that focus on providing comfort and utility are a growing trend. Manufacturers have made catheters with comfort as a guiding principle to minimize pain and ultimately create an overall user experience. The latest trends that are commonly observed include minimal frictional drag on insertion, ease of handling, and discrete packaging. This is yet another massive market shift in the healthcare sector that aims to realize patient outcomes and satisfaction. 

North America garnered a revenue share of over 34.4% in 2023 and is expected to increase multifold in the future. The regional market is currently showing high growth attributed to the increasing incidence of targeted diseases including bladder obstruction, UI, Benign Prostate Hyperplasia (BPH), urine retention, and bladder cancer. According to the National Association for Continence, Urine urgency and Overactive Bladder (OAB) are common to people 40 years of age and older. According to the American Society of Nephrology, urologic disorders account for approximately 47% of all physician visits and are ranked as the third most common complaint among Americans aged 65 and older.